Compare Pfizer Inc (PFE) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Skyworks Solutions Inc — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Skyworks Solutions Inc trades at $63.28 (market cap $9.47B). The key difference: Pfizer Inc is far larger — about 15× Skyworks Solutions Inc's market cap, and Pfizer Inc pays the higher dividend (6.9%). Which is the better fit depends on your goals.
| PFE | SWKS | |
|---|---|---|
Market Cap | $142.14B | $9.47B |
Volume | 29,869,932 | — |
Sector | Health | Technology |
52-Week High | $28.56 | $83.40 |
52-Week Low | $23.29 | $52.50 |
Enterprise Value | $192.80B | $9.24B |
Dividend Yield | 6.9% | 4.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
Skyworks Solutions (SWKS) trades at $62.95, up 6.14% on the day, with a bearish technical signal but strong fundamental valuation metrics including a P/E of 24.91 and P/S of 2.22. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results pending. Recent news highlights ongoing investigations into corporate governance alongside positive coverage of its EV and AI semiconductor innovations.
The stock presents a mixed outlook: analyst consensus is bullish with a $75.88 price target (35 Buy, 23 Hold, 2 Sell), but risks include declining revenue trends (2025: $4.09B, 2026 est: $4.0B), margin compression, and legal scrutiny. Near-term catalysts depend on Q2 earnings beat potential and EV/AI segment growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
